Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$140,000.00

Risk-stratified breast cancer screening: Validation and implementation of risk prediction tools in diverse populations

EF 2024-25

Résumé
Do you know that every day in Canada, on average 85 women are diagnosed with breast cancer and 15 die from the disease? To reduce breast cancer mortality and improve treatment options, mammography screening as part of provincial population-based programs, is offered to Canadian women aged 50 to 74 every 2 or 3 years. However, almost 20% of new breast cancer cases occur in women under the age of 50. Furthermore, screening participation rates is lower in certain groups of the population including first nations, immigrants and ethnic or racial minorities. To ensure equitable and timely access to screening while balancing its benefits against the potential harms such as false-positive screening results, overdiagnosis, overtreatment, and the associated anxiety, risk-stratified screening is considered as a feasible alternative to current aged-based programs. In fact, it is well known that some women have different factors that considerably increase their risk of breast cancer. Among these factors are small variations in the DNA that individually have little to no effect on health. However, when they are combined, they can significantly influence the risk of developing the disease. Other factors such as the family history of cancer, breast density, body mass index and lifestyle habits should also be taken into account when assessing the risk of breast cancer. Therefore, by putting all these factors together and incorporating them into a prediction tool that can take the form of a simple application on a computer, we can estimate the risk of a woman to develop breast cancer during her lifetime. Yet, we still need to verify if the estimate is as accurate as possible, otherwise the tool may not be useful. To do so, the tool has to be validated in the population in which it will be used. This is precisely the aim of our research: assessing if a breast cancer risk prediction tool is ready to be used in a diverse population while ensuring equity and accessibility for all groups.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
513771
Name
Mbuya-Bienge Cynthia
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Risk-stratified breast cancer screening: Validation and implementation of risk prediction tools in diverse populations
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$140,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Breast Cancer; Model Validation; Polygenic Risk Score (Prs); Risk Prediction Tools; Risk-Stratified Screening
Abstract
Do you know that every day in Canada, on average 85 women are diagnosed with breast cancer and 15 die from the disease? To reduce breast cancer mortality and improve treatment options, mammography screening as part of provincial population-based programs, is offered to Canadian women aged 50 to 74 every 2 or 3 years. However, almost 20% of new breast cancer cases occur in women under the age of 50. Furthermore, screening participation rates is lower in certain groups of the population including first nations, immigrants and ethnic or racial minorities. To ensure equitable and timely access to screening while balancing its benefits against the potential harms such as false-positive screening results, overdiagnosis, overtreatment, and the associated anxiety, risk-stratified screening is considered as a feasible alternative to current aged-based programs. In fact, it is well known that some women have different factors that considerably increase their risk of breast cancer. Among these factors are small variations in the DNA that individually have little to no effect on health. However, when they are combined, they can significantly influence the risk of developing the disease. Other factors such as the family history of cancer, breast density, body mass index and lifestyle habits should also be taken into account when assessing the risk of breast cancer. Therefore, by putting all these factors together and incorporating them into a prediction tool that can take the form of a simple application on a computer, we can estimate the risk of a woman to develop breast cancer during her lifetime. Yet, we still need to verify if the estimate is as accurate as possible, otherwise the tool may not be useful. To do so, the tool has to be validated in the population in which it will be used. This is precisely the aim of our research: assessing if a breast cancer risk prediction tool is ready to be used in a diverse population while ensuring equity and accessibility for all groups.
Competitiondate
202410
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Mbuya-Bienge, Cynthia
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $140,000~ $0~